T-cell dysregulation in systemic lupus erythematosus: a four-layered model from extracellular cues to epigenetic remodeling and therapeutic opportunities.
Oct 2026· Autoimmunity Reviews· pp.
104217
· 0 citations· 315 references
Medicine
TL;DR
The spectrum of T-cell abnormalities in SLE is synthesized and it is proposed that these phenotypes arise from four interacting layers of dysregulation: extracellular cues including cytokine and non-cytokine mediators and altered antigen presentation, T-cell receptor (TCR) and co-stimulatory signaling, immunometabolic reprogramming, and epigenetic remodeling spanning DNA methylation, RNA modifications and histone post-translational modifications.
Abstract
Systemic lupus erythematosus (SLE) is a heterogeneous, multisystem autoimmune disease in which the breakdown of T-cell tolerance is increasingly recognized as a central and therapeutically tractable event. Herein, we synthesize the spectrum of T-cell abnormalities in SLE and elucidate the underlying molecular mechanisms. SLE T cells show expanded B-cell-helper (Tfh/Tph), Th17 and double-negative populations, deficient or dysfunctional regulatory T cells, an intrarenal Th1 bias, clonally expanded cytotoxic and tissue-resident memory CD8+ cells, and expanded IL-10-producing Th10 and age-associated helper T-cell states. We propose that these phenotypes arise from four interacting layers of dysregulation: extracellular cues including cytokine and non-cytokine mediators and altered antigen presentation, T-cell receptor (TCR) and co-stimulatory signaling, immunometabolic reprogramming, and epigenetic remodeling spanning DNA methylation, RNA modifications and histone post-translational modifications (PTMs). We highlight an integrated metabolic-epigenetic axis, in which metabolites act as obligatory substrates or cofactors for the enzymes that write and erase chromatin marks, and we identify the PP2A signaling axis, CaMK4 and mTOR as hubs that act across several layers at once, so that the layers are bidirectionally coupled rather than arranged in a single causal direction. Finally, we discuss how these mechanisms inform an evolving therapeutic landscape.
Findings identify circulating GZMK as an independent correlate of SLE clinical activity and characterize a recurrent GZMK-enriched CD8 + memory/Tem cell program across peripheral blood and affected tissues that is associated with B-cell dysregulation and plasma-cell-related immune abnormalities.
Yun-Jing Pu, Zhong-Yu Chen, Pei-Hui Yang et al.· Frontiers in Immunology· 0 citations
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease driven by loss of immune tolerance, dysregulated nucleic acid sensing and cytokine signaling, abnormal B- and T-cell activation, persistent autoantibody production, and impaired clearance of immune cells and debris. These interconnected abnormalit...
Yu-Rin Kim, E. Yeo, I. Kang· Current Issues in Molecular...· 0 citations
The PD-1/PD-L1 immune checkpoint pathway serves as a core regulatory hub that maintains peripheral immune tolerance. In different disease contexts, this axis exhibits opposing outcomes. In cancer, sustained antigenic stimulation elevates PD-1 expression and locks T cells into an exhaustion phenotype-a state characteriz...
Systemic autoimmune diseases arise from a heterogeneous interplay of genetic, epigenetic, and environmental factors that culminates in loss of tolerance, chronic inflammation, and tissue injury. Among the pathways linking susceptibility to effector disease, CD40-CD40L is a central regulator of antigen presentation, T-B...
M. Hashimoto, M. Katsushima, F. Mackay et al.· Rheumatology· 0 citations
This review synthesizes current understanding of disease mechanisms, molecular profiling evidence, biomarker candidates, and mechanism-directed therapies corresponding to each tissue injury program and delineates the design requirements for prospective biomarker-stratified trials essential to validating molecularly gui...
Jun Zhou, Wei Xiao, Hui Jian· Frontiers in Immunology· 0 citations
This review summarizes recent advances in T-cell metabolic reprogramming in SLE and its potential relationship to senescent-like and exhausted-like T-cell states.
Yi Zou, Zhi-Chu Ren, Yuki Kudo et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.